K. Avci Et Al. , "Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells," MOLECULAR BIOLOGY , vol.58, no.6, pp.1268-1279, 2024
Avci, K. Et Al. 2024. Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells. MOLECULAR BIOLOGY , vol.58, no.6 , 1268-1279.
Avci, K., Erdogan, M. O., Yildiz, S. H., & YAVAŞOĞLU, F., (2024). Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells. MOLECULAR BIOLOGY , vol.58, no.6, 1268-1279.
Avci, K. Et Al. "Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells," MOLECULAR BIOLOGY , vol.58, no.6, 1268-1279, 2024
Avci, K. Et Al. "Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells." MOLECULAR BIOLOGY , vol.58, no.6, pp.1268-1279, 2024
Avci, K. Et Al. (2024) . "Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells." MOLECULAR BIOLOGY , vol.58, no.6, pp.1268-1279.
@article{article, author={K. Avci Et Al. }, title={Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells}, journal={MOLECULAR BIOLOGY}, year=2024, pages={1268-1279} }